Combination of 13-Cis Retinoic Acid and Lovastatin: Marked Antitumor Potential In Vivo in a Pheochromocytoma Allograft Model in Female Athymic Nude Mice

Clicks: 170
ID: 270906
2014
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #83 of 213 articles by views in endocrinology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 213 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Currently, there are no reliably effective therapeutic options for metastatic pheochromocytoma (PCC) and paraganglioma. Moreover, there are no therapies that ma
Reference Key
svenja2014endocrinologycombination Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Nölting, Svenja;Giubellino, Alessio;Tayem, Yasin;Young, Karen;Lauseker, Michael;Bullova, Petra;Schovanek, Jan;Anver, Miriam;Fliedner, Stephanie;Korbonits, Márta;Göke, Burkhard;Vlotides, George;Grossman, Ashley;Pacak, Karel;
Journal endocrinology
Year 2014
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.